REVIVA PHARMACEUTICALS HOLDI (RVPH) Stock Analyst Earnings Estimates
NASDAQ:RVPH - Nasdaq - US76152G1004 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 216.96% | N/A 106.44% | N/A 81.51% | N/A 32.63% | N/A 23.48% | |||||
| EBITDA YoY % growth | N/A | -720K | -10.1M -1,302.78% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -150K | -720K -380.00% | -10.1M -1,302.78% | -24.31M -140.69% | N/A -65.62% | N/A 14.84% | N/A -20.90% | N/A -3.95% | N/A 95.86% | N/A 6,155.71% | N/A 157.38% | N/A 95.30% | N/A 38.06% | N/A 24.99% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -0.56 -222.95% | -1.25 -123.21% | -1.64 -31.20% | N/A 41.02% | N/A 9.84% | N/A 36.84% | N/A 22.22% | N/A 221.43% | N/A 131.37% | N/A 155.93% | N/A 35.43% | N/A 22.25% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.24 32.48% | -0.25 -0.64% | -0.26 1.92% | -0.24 3.44% | -0.24 -2.16% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.209M 7.80% | -8.772M -10.73% | -8.976M -10.41% | -9.282M -9.68% | -9.486M -3.01% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.25 43.18% | -0.25 | 0.00 | 0.37% |
| Q2 2024 Q2Q % growth | -0.26 52.73% | -0.30 | 0.04 | 12.10% |
| Q1 2024 Q2Q % growth | -0.25 16.67% | -0.38 | 0.13 | 34.93% |
| Q4 2023 Q2Q % growth | -0.35 7.89% | -0.36 | 0.01 | 2.66% |
| Q3 2023 Q2Q % growth | -0.44 -144.44% | -0.37 | -0.07 | -17.86% |
| Q2 2023 Q2Q % growth | -0.55 -89.66% | -0.28 | -0.27 | -95.37% |
| Q1 2023 Q2Q % growth | -0.30 25.00% | -0.33 | 0.03 | 9.50% |
| Q4 2022 Q2Q % growth | -0.38 -72.73% | -0.22 | -0.16 | -69.34% |
| Q3 2022 Q2Q % growth | -0.18 -50.00% | -0.29 | 0.11 | 38.44% |
| Q2 2022 Q2Q % growth | -0.29 -141.67% | -0.36 | 0.07 | 18.77% |
| Q1 2022 Q2Q % growth | -0.40 -300.00% | -0.29 | -0.11 | -40.06% |
| Q4 2021 Q2Q % growth | -0.22 -259.48% | -0.26 | 0.04 | 13.73% |
| Q3 2021 Q2Q % growth | -0.12 -96.08% | -0.24 | 0.12 | 49.94% |
| Q2 2021 Q2Q % growth | -0.12 | -0.24 | 0.12 | 50.98% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 19.42% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |